Related Experiment Video
Updated: Apr 26, 2026

07:34
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
1.5K
Histopathological screening for prostate carcinoma: is a benign biopsy a negative biopsy?
Verena Sailer1, Glen Kristiansen
1Institute of Pathology, University Hospital of Bonn, Bonn, Germany.
Abstract:
In case of clinical suspicion of a prostate malignancy, a prostate biopsy is the most widely used approach to confirm prostate cancer. Unfortunately, exclusion of prostate cancer is not feasible by means of biopsy and also the negative rate remains consistently high. Here, we review the information the surgical pathologist can still gain from a prostate biopsy in absence of overt carcinoma.

